𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single‐Dose Pharmacokinetics and Safety of Pegylated Interferon‐α2b in Patients with Chronic Renal Dysfunction

✍ Scribed by Gupta, Samir K. (author);Pittenger, Amy L. (author);Swan, Suzanne K. (author);Marbury, Thomas C. (author);Tobillo, Emlyn (author);Batra, Vijay (author);Sack, Marshall (author);Glue, Paul (author);Jacobs, Sheila (author);Affrime, Melton (author)

Book ID
111864686
Publisher
Wiley
Year
2002
Tongue
English
Weight
137 KB
Volume
42
Category
Article
ISSN
0091-2700

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic/pharmacodynamic analysis
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
✍ A. I. Daud; C. Xu; W.-J. Hwu; P. Urbas; S. Andrews; N. E. Papadopoulos; L. C. Fl 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 369 KB

## Purpose High-dose pegylated interferon α-2b (peginterferon α-2b) significantly decreased disease recurrence in patients with resected stage III melanoma in a clinical study. We investigated the pharmacokinetics (PK) and safety of high-dose peginterferon α-2b in patients with high-risk melanoma.